Tijaria Polypip Standalone March 2020 Net Sales at Rs 12.82 crore, down 49.57% Y-o-Y
July 01, 2020 / 10:56 AM IST
Reported Standalone quarterly numbers for Tijaria Polypipes are:Net Sales at Rs 12.82 crore in March 2020 down 49.57% from Rs. 25.42 crore in March 2019.
Quarterly Net Loss at Rs. 3.03 crore in March 2020 down 375.33% from Rs. 1.10 crore in March 2019.
EBITDA stands negative at Rs. 0.28 crore in March 2020 down 106.06% from Rs. 4.62 crore in March 2019.
Tijaria Polypip shares closed at 7.80 on June 30, 2020 (NSE) and has given 6.12% returns over the last 6 months and -46.39% over the last 12 months.
| Tijaria Polypipes | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'20 | Dec'19 | Mar'19 | | Net Sales/Income from operations | 12.82 | 21.09 | 25.42 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 12.82 | 21.09 | 25.42 | | EXPENDITURE | | Consumption of Raw Materials | 6.93 | 10.59 | 12.25 | | Purchase of Traded Goods | 2.49 | 0.07 | 0.54 | | Increase/Decrease in Stocks | -0.11 | 1.42 | 3.24 | | Power & Fuel | -- | -- | -- | | Employees Cost | 0.66 | 0.87 | 0.61 | | Depreciation | 1.31 | 1.31 | 1.55 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 3.29 | 5.07 | 4.30 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -1.74 | 1.76 | 2.93 | | Other Income | 0.15 | 0.05 | 0.13 | | P/L Before Int., Excpt. Items & Tax | -1.59 | 1.82 | 3.07 | | Interest | 1.46 | 1.77 | 1.96 | | P/L Before Exceptional Items & Tax | -3.05 | 0.05 | 1.10 | | Exceptional Items | 0.02 | -0.01 | 0.00 | | P/L Before Tax | -3.03 | 0.04 | 1.10 | | Tax | -- | -- | -- | | P/L After Tax from Ordinary Activities | -3.03 | 0.04 | 1.10 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | 0.00 | -- | | Net Profit/(Loss) For the Period | -3.03 | 0.04 | 1.10 | | Equity Share Capital | 28.63 | 28.63 | 26.72 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -1.08 | 0.01 | 0.41 | | Diluted EPS | -1.08 | 0.01 | 0.41 | | EPS After Extra Ordinary | | Basic EPS | -1.08 | 0.01 | 0.41 | | Diluted EPS | -1.08 | 0.01 | 0.41 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
US export curbs on COVID-19 vaccine ingredients limiting efforts to scale up production: Adar Poonawalla Watch more 
French IT firm Capgemini to cover vaccination costs of India employees, their dependents Watch more 
Women's Day Special: Byju's co-founder Divya Gokulnath on Moneycontrol Watch more 
Haryana’s 75% reservation law may disrupt post-COVID-19 recovery, say firms Watch more 
